Prostate Cancer

Tools needed to reliably report side effects in chemotherapy clinical trials

Published in Cancer Weekly, June 29th, 2004

Almost half the symptoms experienced by patients enrolled in chemotherapy clinical trials are not reported by their clinician, according to a study conducted by Oregon Health & Science University (OHSU) Cancer Institute researchers.

"Our data suggest that clinician assessment alone should not be relied upon in reporting side effects in chemotherapy clinical trials," said Tomasz M. Beer, MD, director of the prostate cancer program in the OHSU Cancer Institute and principal investigator of the study. "If verified, these findings strongly suggest that new tools for patient reporting of symptoms should be developed for use in chemotherapy clinical trials."

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-06-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry